Table 1 Baseline characteristics of 130 unique IBD patients admitted to MVMC between 2007 and 2013 (n = 130)

Age (year, x ± s)

59.8 ± 15.2

Male (n (%))

125 (96.2)

Caucasian (n (%))

118 (90.8)

History of psychiatric disorder

66 (50.8)

 Crohn’s disease

74 (56.9)

 Ulcerative colitis

56 (43.1)

Duration of IBD (year, median(IQR))

15 (5.0-30.3)

History of bowel resection (n (%))

75 (57.7)

 5-ASA

45 (34.6)

 Immunomodulator (AZA/6-MP or MTX)

27 (20.8)

 Anti-TNF

12 (9.2)

 Steroids

25 (19.2)

Patient who has not been on IBD medication prior to admission (n (%))

37 (28.5)